Table 2.

Differences in spinal CSF biomarker concentrations between TN patients and controls.

Biomarker	Coefficient	p (lm)	q (lm)
Clec11a	0.85	5.46 × 10−5	0.0037
LGMN	0.59	0.00015	0.0037
MFG-E8	0.79	0.00016	0.0037
ANGPTL-4	0.60	0.00097	0.017

The table demonstrates the significant CSF biomarkers that differed between TN patients and controls. Each biomarker was analyzed using linear regression, adjusting for age and sex. The first column is the regression coefficient (positive value if higher biomarker concentration in the TN group), second column is the p- and third column contain q-values (FDR (Benjamini–Hochberg) adjusted p-values). Only proteins that were significant at the 5% FDR level are included in the table.